{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:02:55Z","timestamp":1791914575941,"version":"4.3.4"},"reference-count":32,"publisher":"Massachusetts Medical Society","issue":"24","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2020,12,10]]},"DOI":"10.1056\/nejmoa2022485","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T12:30:16Z","timestamp":1600605016000},"page":"2345-2357","source":"Crossref","is-referenced-by-count":746,"title":["Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.1056","volume":"383","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-595X","authenticated-orcid":false,"given":"Maha","family":"Hussain","sequence":"first","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Mateo","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Shore","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahneen","family":"Sandhu","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim N.","family":"Chi","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8777-7343","authenticated-orcid":false,"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Olmos","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Thiery-Vuillemin","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Twardowski","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Roubaud","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00d6zg\u00fcro\u011flu","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Kang","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Burgents","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gresty","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Corcoran","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Adelman","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-595X","authenticated-orcid":false,"given":"Johann","family":"de Bono","sequence":"additional","affiliation":[{"name":"From the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago (M.H.); Vall d\u2019Hebron Institute of Oncology and Vall d\u2019Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga, M\u00e1laga (D.O.) \u2014 all in Spain; Institut Gustave Roussy, University of Paris Saclay, Villejuif (K.F.), the Department of Medical Oncology, Centre Hospitalier Universitaire..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.01.012"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0937"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.02.023"},{"key":"e_1_3_5_5_2","first-page":"597","article-title":"A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer.","volume":"55","author":"Lang SH","year":"2019","unstructured":"Lang SH, Swift SL, White H, Misso K, Kleijnen J, Quek RGW. A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer. Int J Oncol 2019;55:597-616.31322208","journal-title":"Int J Oncol"},{"key":"e_1_3_5_6_2","first-page":"10.1200\/PO.17.0","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making.","volume":"2017","author":"Abida W","year":"2017","unstructured":"Abida W, Armenia J, Gopalan A, et al. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making. JCO Precis Oncol 2017;2017:10.1200\/PO.17.00029-10.1200\/PO.17.00029.28825054","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.11.033"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.1882"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.022"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.10.009"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00358"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.383"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.30"},{"key":"e_1_3_5_14_2","first-page":"200","article-title":"Imaging and treatment recommendations in patients with castrate-resistant prostate cancer.","volume":"19","author":"Albala DM","year":"2017","unstructured":"Albala DM. Imaging and treatment recommendations in patients with castrate-resistant prostate cancer. Rev Urol 2017;19:200-202.29302247","journal-title":"Rev Urol"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0394"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2728"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt074"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506859"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.202"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30684-9"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_5_24_2","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. 2010 (https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf)."},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2307\/2530245"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/03610929108830654"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","unstructured":"Latimer NR Abrams KR. NICE DSU technical support document 16: adjusting survival time estimates in the presence of treatment switching. Sheffield United Kingdom: National Institute for Health and Care Excellence Decision Support Unit July 2014 (http:\/\/nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD16_Treatment_Switching.pdf).","DOI":"10.1016\/j.jval.2013.08.013"},{"key":"e_1_3_5_28_2","unstructured":"Lynparza (olaparib) tablets for oral use. Gaithersburg MD: AstraZeneca 2020 (package insert) (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/208558s014lbl.pdf)."},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30688-6"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.07.035"},{"key":"e_1_3_5_31_2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: prostate cancer v1. 2020 (https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf)."},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911206"},{"key":"e_1_3_5_33_2","unstructured":"Jevtana (cabazitaxel) injection for intravenous use. Bridgewater NJ: AstraZeneca 2020 (package insert) (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/201023s023lbl.pdf)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2022485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T21:08:20Z","timestamp":1711487300000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2022485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":32,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12,10]]}},"alternative-id":["10.1056\/NEJMoa2022485"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2022485","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738707680.793580401","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}